Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07121569) titled 'Oral DLBS1033 as Adjunctive Therapy in Acute Ischemic Stroke: Impact on Inflammatory Biomarkers and Outcomes' on Aug. 6.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Universitas Sebelas Maret
Condition:
Ischemic Stroke, Acute
Intervention:
Drug: Oral lumbrokinase DLBS1033
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: July 6, 2024
Target Sample Size: 52
Countries of Recruitment:
Indonesia
To know more, visit https://clinical...